Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)A Phase I Study of ZN-d5 in Chinese Subjects With Non-Hodgkin Lymphoma
- First Posted Date
- 2021-11-19
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- Zentera Therapeutics HK Limited
- Target Recruit Count
- 8
- Registration Number
- NCT05127811
- Locations
- 🇨🇳
BeiJing Cancer Hospital, BeiJing, Beijing, China
🇨🇳Sun Yan Set University Cancer Center, Guangzhou, Guangdong, China
🇨🇳Fudan University Shanghai Cancer Hospital, Shanghai, Shanghai, China
A Phase 1b Study of ZN-c3 in Chinese Subjects
- First Posted Date
- 2021-07-22
- Last Posted Date
- 2021-09-05
- Lead Sponsor
- Zentera Therapeutics HK Limited
- Target Recruit Count
- 38
- Registration Number
- NCT04972422
- Locations
- 🇨🇳
Fudan University Zhongshan Hospital, Shanghai, Shanghai, China
🇨🇳Sichuan University Huaxi Hospital, Chengdu, Sichuan, China
🇨🇳Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China
A PHASE 1B STUDY OF ZN-C5 IN CHINESE SUBJECTS
- First Posted Date
- 2021-04-21
- Last Posted Date
- 2022-08-11
- Lead Sponsor
- Zentera Therapeutics HK Limited
- Target Recruit Count
- 12
- Registration Number
- NCT04852419
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, China
News
No news found